Triamcinolone: new and old indications.
Triamcinolone is a commonly used synthetic corticosteroid that has recently been tested in a large clinical trial for chronic obstructive pulmonary disease and shown to have some benefits. To our knowledge, there are no reviews of the pharmacotherapy of triamcinolone. This review has a brief overview of the pharmacology of triamcinolone, followed by a discussion of the clinical trials with triamcinolone. Triamcinolone is used in the treatment of respiratory inflammation, rheumatoid arthritis and a variety of other inflammatory conditions.
Doggrell
S A
SA
Doggrell Biomedical Communications, Lynfield, Auckland, New Zealand. s_doggrell@yahoo.com
D000281:Administration, Intranasal; D000328:Adult; D000336:Aerosols; D000730:Androstadienes / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D016589:Astemizole / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy; D002648:Child; D002986:Clinical Trials as Topic; D003233:Conjunctivitis, Allergic / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D000068298:Fluticasone; D006801:Humans; D007273:Injections, Intramuscular; D017336:Loratadine / Q000627:therapeutic use; D008173:Lung Diseases, Obstructive / Q000188:drug therapy; D008268:Macular Degeneration / Q000188:drug therapy; D015394:Molecular Structure; D009297:Nasal Mucosa / Q000187:drug effects; D012221:Rhinitis, Allergic, Perennial / Q000209:etiology; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy; D013329:Structure-Activity Relationship; D014221:Triamcinolone / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
D000336:Aerosols; D000730:Androstadienes; D000893:Anti-Inflammatory Agents; D014221:Triamcinolone; D017336:Loratadine; D016589:Astemizole; D000068298:Fluticasone